These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39331392)

  • 21. Development of an intravenous low-dose buprenorphine initiation protocol.
    Jablonski LA; Bodnar AR; Stewart RW
    Drug Alcohol Depend; 2022 Aug; 237():109541. PubMed ID: 35753281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid Low-dose Buprenorphine Initiation for Hospitalized Patients With Opioid Use Disorder.
    Sokolski E; Skogrand E; Goff A; Englander H
    J Addict Med; 2023 Jul-Aug 01; 17(4):e278-e280. PubMed ID: 37579112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments.
    Kumar P; Kaliamurthy S; Thomas J
    Pediatrics; 2024 Aug; 154(2):. PubMed ID: 38966873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fentanyl withdrawal: Understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance.
    Luba R; Jones J; Choi CJ; Comer S
    Addiction; 2023 Apr; 118(4):719-726. PubMed ID: 36444486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Emergency Department-Initiated Buprenorphine on Repeat Emergency Department Utilization.
    Skains RM; Reynolds L; Carlisle N; Heath S; Covington W; Hornbuckle K; Walter L
    West J Emerg Med; 2023 Nov; 24(6):1010-1017. PubMed ID: 38165181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful Buprenorphine/Naloxone Low-dose Induction in Pregnancy: A Case Report.
    Coish R; Hardial J
    J Addict Med; 2023 Jan-Feb 01; 17(1):114-116. PubMed ID: 35916416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Dose Buprenorphine Initiation in the Management of Opioid Use Disorder in Pregnancy.
    Berry M; Kiefer MK; Hinely KA; Bowden H; Jordan A; Vilensky M; Rood KM
    Obstet Gynecol; 2024 Jun; 143(6):815-818. PubMed ID: 38574367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.
    Cisewski DH; Santos C; Koyfman A; Long B
    Am J Emerg Med; 2019 Jan; 37(1):143-150. PubMed ID: 30355476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report.
    Szczesniak LM; Calleo VJ; Sullivan RW
    Harm Reduct J; 2020 Oct; 17(1):71. PubMed ID: 33028340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid Overlap Initiation Protocol Using Low Dose Buprenorphine for Opioid Use Disorder Treatment in an Outpatient Setting: A Case Series.
    Suen LW; Lee TG; Silva M; Walton P; Coffin PO; Geier M; Soran CS
    J Addict Med; 2022 Sep-Oct 01; 16(5):534-540. PubMed ID: 35149614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder.
    Azar P; Schneiderman H; Barron H; Wong JSH; Meyer M; Newman-Azar D; Narimani M; Ignaszewski MJ; Mathew N; Mullen R; Krausz RM; Maharaj AR
    Addict Sci Clin Pract; 2024 Jun; 19(1):50. PubMed ID: 38886826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder.
    Herring AA; Vosooghi AA; Luftig J; Anderson ES; Zhao X; Dziura J; Hawk KF; McCormack RP; Saxon A; D'Onofrio G
    JAMA Netw Open; 2021 Jul; 4(7):e2117128. PubMed ID: 34264326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Macrodosing" Sublingual Buprenorphine and Extended-release Buprenorphine in a Hospital Setting: 2 Case Reports.
    Kahan M; Marion-Bellemare L; Samson J; Srivastava A
    J Addict Med; 2023 Jul-Aug 01; 17(4):485-487. PubMed ID: 37579117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.
    Lintzeris N; Dunlop AJ; Haber PS; Lubman DI; Graham R; Hutchinson S; Arunogiri S; Hayes V; Hjelmström P; Svedberg A; Peterson S; Tiberg F
    JAMA Netw Open; 2021 May; 4(5):e219041. PubMed ID: 33970256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees.
    Hammerslag LR; Mack A; Chandler RK; Fanucchi LC; Feaster DJ; LaRochelle MR; Lofwall MR; Nau M; Villani J; Walsh SL; Westgate PM; Slavova S; Talbert JC
    JAMA Netw Open; 2023 Oct; 6(10):e2336914. PubMed ID: 37851446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl.
    Varshneya NB; Thakrar AP; Hobelmann JG; Dunn KE; Huhn AS
    J Addict Med; 2022 Jul-Aug 01; 16(4):e265-e268. PubMed ID: 34816821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder.
    Schroeder JR; Phillips KA; Epstein DH; Jobes ML; Furnari MA; Kennedy AP; Heilig M; Preston KL
    Psychopharmacology (Berl); 2018 Oct; 235(10):2957-2966. PubMed ID: 30079432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose buprenorphine initiation in the era of fentanyl and fentanyl analogs: A case series of outpatient inductions.
    Ahmed S; Faruqui Z; Poddar K; Bhivandkar S; Suzuki J
    J Opioid Manag; 2023; 19(5):455-460. PubMed ID: 37968979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder.
    Szczesniak L; Britton S; Rn TB; Sullivan R
    Harm Reduct J; 2024 Jun; 21(1):114. PubMed ID: 38849912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.